Marlborough-Based Hologic’s COVID-19 Tests Detect Omicron Variant
In full transparency, the following press release was submitted to SOURCE media through its business wire service. *** MARLBOROUGH –
Read moreIn full transparency, the following press release was submitted to SOURCE media through its business wire service. *** MARLBOROUGH –
Read moreIn full transparency, the following press release was submitted to SOURCE media via a business wire service. *** MARLBOROUGH –
Read moreIn full transparency, the following is a press release that was sent to SOURCE media through its business wire service.
Read moreIn full transparency, the following was submitted to SOURCE media through its business wire service. *** MARLBOROUG – Hologic announced
Read moreThe following is a press release submitted to SOURCE through its business wire service. *** MARLBOROUGH – Hologic, Inc. has
Read more*** The following is a press release submitted to SOURCE media through its business wire service. *** MARLBOROUGH – Marlborough-based
Read moreMARLBOROUGH – Hologic, Inc. announced today, October 6, its Aptima® SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA) from
Read moreThe press release was submitted to SOURCE media through its business wire. *** MARLBOROUGH – Hologic, Inc., a medical technology
Read moreThe following is a press release *** MARLBOROUGH – A molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV)
Read more